Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nicholas W. Fischer, Aaron Prodeus, David Malkin & Jean Gariépy. (2016) p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis. Cell Cycle 15:23, pages 3210-3219.
Read now
Read now
Petra Baresova, Jana Musilova, Paula M. Pitha & Barbora Lubyova. (2014) p53 Tumor Suppressor Protein Stability and Transcriptional Activity Are Targeted by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factor 3. Molecular and Cellular Biology 34:3, pages 386-399.
Read now
Read now
Lorna Jane Warnock, Sally Anne Raines & Jo Milner. (2011) Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53. Cancer Biology & Therapy 12:12, pages 1059-1068.
Read now
Read now
Karen A Boehme & Christine Blattner. (2009) Regulation of p53 - insights into a complex process. Critical Reviews in Biochemistry and Molecular Biology 44:6, pages 367-392.
Read now
Read now
Articles from other publishers (16)
Joshua H. Choe, Tatsuya Kawase, An Xu, Asja Guzman, Aleksandar Z. Obradovic, Ana Maria Low-Calle, Bita Alaghebandan, Ananya Raghavan, Kaitlin Long, Paul M. Hwang, Joshua D. Schiffman, Yan Zhu, Ruiying Zhao, Dung-Fang Lee, Chen Katz & Carol Prives. (2023) Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death. Cancer Discovery 13:5, pages 1250-1273.
Crossref
Crossref
Maurizio Capuozzo, Mariachiara Santorsola, Marco Bocchetti, Francesco Perri, Marco Cascella, Vincenza Granata, Venere Celotto, Oreste Gualillo, Alessia Maria Cossu, Guglielmo Nasti, Michele Caraglia & Alessandro Ottaiano. (2022) p53: From Fundamental Biology to Clinical Applications in Cancer. Biology 11:9, pages 1325.
Crossref
Crossref
Yuzhi Zhang, Pingping Liu, Hao Fu, Dongdong Wang, Dan Zhao, Jiachan Zhang, Changtao Wang & Meng Li. (2022) Effects of Lactobacillus kefiri fermentation supernatant on skin aging caused by oxidative stress. Journal of Functional Foods 96, pages 105222.
Crossref
Crossref
Liz J. Hernández Borrero & Wafik S. El-Deiry. (2021) Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188556.
Crossref
Crossref
Kaori Fukuzawa, Shigenori Tanaka, Yoichiro Yagi, Noriyuki Kurita, Norihito Kawashita, Kenichiro Takaba & Teruki Honma. 2021. Recent Advances of the Fragment Molecular Orbital Method. Recent Advances of the Fragment Molecular Orbital Method
127
181
.
Jovanka Gencel-Augusto & Guillermina Lozano. (2020) p53 tetramerization: at the center of the dominant-negative effect of mutant p53. Genes & Development 34:17-18, pages 1128-1146.
Crossref
Crossref
Ling Chen, Shuang Liu & Yongguang Tao. (2020) Regulating tumor suppressor genes: post-translational modifications. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Chen Katz, Ana Maria Low-Calle, Joshua H. Choe, Oleg Laptenko, David Tong, Jazmine-Saskya N. Joseph-Chowdhury, Francesca Garofalo, Yan Zhu, Assaf Friedler & Carol Prives. (2018) Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers. Genes & Development 32:5-6, pages 430-447.
Crossref
Crossref
Mengying Wu, Jiahui An, Qidi Zheng, Xiaoru Xin, Zhuojia Lin, Xiaonan Li, Haiyan Li & Dongdong Lu. (2016) Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR. Oncotarget 7:41, pages 66525-66539.
Crossref
Crossref
Anna Etzold, Julia C. Schröder, Oliver Bartsch, Ulrich Zechner & Danuta Galetzka. (2014) Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li–Fraumeni syndrome. Familial Cancer 14:1, pages 161-165.
Crossref
Crossref
Xiaona Ji, Qiang Huang, Long Yu, Ruth Nussinov & Buyong Ma. (2014) Bioinformatics Study of Cancer-Related Mutations within p53 Phosphorylation Site Motifs. International Journal of Molecular Sciences 15:8, pages 13275-13298.
Crossref
Crossref
Thuy-Ai Nguyen, Daniel Menendez, Michael A. Resnick & Carl W. Anderson. (2014) Mutant TP53 Posttranslational Modifications: Challenges and Opportunities. Human Mutation 35:6, pages 738-755.
Crossref
Crossref
Wakana Ono, Yuki Hayashi, Wataru Yokoyama, Takao Kuroda, Hiroyuki Kishimoto, Ichiaki Ito, Keiji Kimura, Kensuke Akaogi, Tsuyoshi Waku & Junn Yanagisawa. (2014) The Nucleolar Protein Myb-binding Protein 1A (MYBBP1A) Enhances p53 Tetramerization and Acetylation in Response to Nucleolar Disruption. Journal of Biological Chemistry 289:8, pages 4928-4940.
Crossref
Crossref
Ting Fu, Hanyi Min, Yong Xu, Jianzhong Chen & Guohui Li. (2012) Molecular Dynamic Simulation Insights into the Normal State and Restoration of p53 Function. International Journal of Molecular Sciences 13:8, pages 9709-9740.
Crossref
Crossref
Rui KamadaRui Kamada. 2012. Tetramer Stability and Functional Regulation of Tumor Suppressor Protein p53. Tetramer Stability and Functional Regulation of Tumor Suppressor Protein p53
13
43
.
Rui Kamada, Takao Nomura, Carl W. Anderson & Kazuyasu Sakaguchi. (2011) Cancer-associated p53 Tetramerization Domain Mutants. Journal of Biological Chemistry 286:1, pages 252-258.
Crossref
Crossref